184 related articles for article (PubMed ID: 29026949)
1. A filamentous bacteriophage targeted to carcinoembryonic antigen induces tumor regression in mouse models of colorectal cancer.
Murgas P; Bustamante N; Araya N; Cruz-Gómez S; Durán E; Gaete D; Oyarce C; López E; Herrada AA; Ferreira N; Pieringer H; Lladser A
Cancer Immunol Immunother; 2018 Feb; 67(2):183-193. PubMed ID: 29026949
[TBL] [Abstract][Full Text] [Related]
2. Liver sinusoidal endothelial cells contribute to CD8 T cell tolerance toward circulating carcinoembryonic antigen in mice.
Höchst B; Schildberg FA; Böttcher J; Metzger C; Huss S; Türler A; Overhaus M; Knoblich A; Schneider B; Pantelis D; Kurts C; Kalff JC; Knolle P; Diehl L
Hepatology; 2012 Nov; 56(5):1924-33. PubMed ID: 22610745
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin.
van Gisbergen KP; Aarnoudse CA; Meijer GA; Geijtenbeek TB; van Kooyk Y
Cancer Res; 2005 Jul; 65(13):5935-44. PubMed ID: 15994972
[TBL] [Abstract][Full Text] [Related]
4. Induction of mucosal and systemic immune responses against human carcinoembryonic antigen by an oral vaccine.
Huang Y; Fayad R; Smock A; Ullrich AM; Qiao L
Cancer Res; 2005 Aug; 65(15):6990-9. PubMed ID: 16061685
[TBL] [Abstract][Full Text] [Related]
5. Efficient induction of anti-tumor immunity by a TAT-CEA fusion protein vaccine with poly(I:C) in a murine colorectal tumor model.
Park JS; Kim HS; Park HM; Kim CH; Kim TG
Vaccine; 2011 Nov; 29(47):8642-8. PubMed ID: 21945963
[TBL] [Abstract][Full Text] [Related]
6. Intrarectal vaccination with recombinant vaccinia virus expressing carcinoembronic antigen induces mucosal and systemic immunity and prevents progression of colorectal cancer.
Kim-Schulze S; Kim HS; Wainstein A; Kim DW; Yang WC; Moroziewicz D; Mong PY; Bereta M; Taback B; Wang Q; Kaufman HL
J Immunol; 2008 Dec; 181(11):8112-9. PubMed ID: 19018004
[TBL] [Abstract][Full Text] [Related]
7. Successful cancer vaccine therapy for carcinoembryonic antigen (CEA)-expressing colon cancer using genetically modified dendritic cells that express CEA and T helper-type 1 cytokines in CEA transgenic mice.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Ishida K; Primus FJ; Yamaue H
Int J Cancer; 2007 Feb; 120(3):585-93. PubMed ID: 17096339
[TBL] [Abstract][Full Text] [Related]
8. Multi-Parameter Quantitative Imaging of Tumor Microenvironments Reveals Perivascular Immune Niches Associated With Anti-Tumor Immunity.
Stoltzfus CR; Sivakumar R; Kunz L; Olin Pope BE; Menietti E; Speziale D; Adelfio R; Bacac M; Colombetti S; Perro M; Gerner MY
Front Immunol; 2021; 12():726492. PubMed ID: 34421928
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of the carcinoembryonic antigen derived peptide 694 in HLA-A2 healthy donors and colorectal carcinoma patients.
Alves PM; Viatte S; Fagerberg T; Michielin O; Bricard G; Bouzourene H; Vuilleumier H; Kruger T; Givel JC; Lévy F; Speiser DE; Cerottini JC; Romero P
Cancer Immunol Immunother; 2007 Nov; 56(11):1795-805. PubMed ID: 17447064
[TBL] [Abstract][Full Text] [Related]
10. CEA Plasmid as Therapeutic DNA Vaccination against Colorectal Cancer.
Veisi Malekshahi Z; Hashemi Goradel N; Shakouri Khomartash M; Maleksabet A; Kadkhodazadeh M; Kardar GA; Negahdari B
Iran J Immunol; 2019 Sep; 16(3):235-245. PubMed ID: 31552832
[TBL] [Abstract][Full Text] [Related]
11. Efficient co-transduction of adenoviral vectors encoding carcinoembryonic antigen and survivin into dendritic cells by the CAR-TAT adaptor molecule enhance anti-tumor immunity in a murine colorectal cancer model.
Kim HS; Kim CH; Park MY; Park JS; Park HM; Sohn HJ; Kim HJ; Kim SG; Oh ST; Kim TG
Immunol Lett; 2010 Jun; 131(1):73-80. PubMed ID: 20211203
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with local radiofrequency ablation and systemic vaccine enhances antitumor immunity and mediates local and distal tumor regression.
Gameiro SR; Higgins JP; Dreher MR; Woods DL; Reddy G; Wood BJ; Guha C; Hodge JW
PLoS One; 2013; 8(7):e70417. PubMed ID: 23894654
[TBL] [Abstract][Full Text] [Related]
13. A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment.
Liu KJ; Chao TY; Chang JY; Cheng AL; Ch'ang HJ; Kao WY; Wu YC; Yu WL; Chung TR; Whang-Peng J
J Biomed Sci; 2016 Aug; 23(1):64. PubMed ID: 27558635
[TBL] [Abstract][Full Text] [Related]
14. Vaccine therapy of established tumors in the absence of autoimmunity.
Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
[TBL] [Abstract][Full Text] [Related]
15. A loss of antitumor therapeutic activity of CEA DNA vaccines is associated with the lack of tumor cells' antigen presentation to Ag-specific CTLs in a colon cancer model.
Ahn E; Kim H; Han KT; Sin JI
Cancer Lett; 2015 Jan; 356(2 Pt B):676-85. PubMed ID: 25449428
[TBL] [Abstract][Full Text] [Related]
16. Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests.
Lesterhuis WJ; de Vries IJ; Schuurhuis DH; Boullart AC; Jacobs JF; de Boer AJ; Scharenborg NM; Brouwer HM; van de Rakt MW; Figdor CG; Ruers TJ; Adema GJ; Punt CJ
Ann Oncol; 2006 Jun; 17(6):974-80. PubMed ID: 16600979
[TBL] [Abstract][Full Text] [Related]
17. Characterization of genetically modified T-cell receptors that recognize the CEA:691-699 peptide in the context of HLA-A2.1 on human colorectal cancer cells.
Parkhurst MR; Joo J; Riley JP; Yu Z; Li Y; Robbins PF; Rosenberg SA
Clin Cancer Res; 2009 Jan; 15(1):169-80. PubMed ID: 19118044
[TBL] [Abstract][Full Text] [Related]
18. Preventive DNA vaccination against CEA-expressing tumors with anti-idiotypic scFv6.C4 DNA in CEA-expressing transgenic mice.
Denapoli PMA; Zanetti BF; Dos Santos AA; de Moraes JZ; Han SW
Cancer Immunol Immunother; 2017 Mar; 66(3):333-342. PubMed ID: 27913835
[TBL] [Abstract][Full Text] [Related]
19. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
[TBL] [Abstract][Full Text] [Related]
20. Significantly increased anti-tumor activity of carcinoembryonic antigen-specific chimeric antigen receptor T cells in combination with recombinant human IL-12.
Chi X; Yang P; Zhang E; Gu J; Xu H; Li M; Gao X; Li X; Zhang Y; Xu H; Hu J
Cancer Med; 2019 Aug; 8(10):4753-4765. PubMed ID: 31237116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
